Clinical trial
A Pilot Study for the Efficacy of Guardian Connect to Modify Lifestyle in Patients With Type 2 Diabetes Mellitus
NCT05150041 is registered in ClinicalTrials.gov with Kangbuk Samsung Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Pilot Study for the Efficacy of Guardian Connect to Modify Lifestyle in Patients With Type 2 Diabetes Mellitus
- Lead sponsor
- Kangbuk Samsung Hospital
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- April 7, 2020
- Completion date
- December 7, 2021
- Enrollment
- 60 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.